The 36-month beta value for ERAS is also noteworthy at 1.16. There are mixed opinions on the stock, with 7 analysts rating it as a “buy,” 1 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
The public float for ERAS is 175.38M, and at present, short sellers hold a 19.22% of that float. The average trading volume of ERAS on October 29, 2024 was 1.88M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ERAS) stock’s latest price update
The stock price of Erasca Inc (NASDAQ: ERAS) has dropped by 0.00 compared to previous close of 2.64. Despite this, the company has seen a fall of -3.30% in its stock price over the last five trading days. globenewswire.com reported 2024-08-12 that In-licensed potential best-in-class pan-RAS molecular glue ERAS-0015 and potential first-in-class pan-KRAS inhibitor ERAS-4001 with a goal of expanding treatment options across RAS-driven tumors
ERAS’s Market Performance
ERAS’s stock has fallen by -3.30% in the past week, with a monthly drop of -1.49% and a quarterly drop of -17.76%. The volatility ratio for the week is 8.15% while the volatility levels for the last 30 days are 6.81% for Erasca Inc The simple moving average for the last 20 days is -0.25% for ERAS’s stock, with a simple moving average of 11.33% for the last 200 days.
Analysts’ Opinion of ERAS
Many brokerage firms have already submitted their reports for ERAS stocks, with CapitalOne repeating the rating for ERAS by listing it as a “Overweight.” The predicted price for ERAS in the upcoming period, according to CapitalOne is $8 based on the research report published on March 11, 2024 of the current year 2024.
BofA Securities, on the other hand, stated in their research note that they expect to see ERAS reach a price target of $6, previously predicting the price at $11. The rating they have provided for ERAS stocks is “Neutral” according to the report published on January 05th, 2024.
H.C. Wainwright gave a rating of “Buy” to ERAS, setting the target price at $10 in the report published on October 11th of the previous year.
ERAS Trading at -4.40% from the 50-Day Moving Average
After a stumble in the market that brought ERAS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -23.48% of loss for the given period.
Volatility was left at 6.81%, however, over the last 30 days, the volatility rate increased by 8.15%, as shares sank -3.30% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -5.71% lower at present.
During the last 5 trading sessions, ERAS fell by -3.30%, which changed the moving average for the period of 200-days by +35.38% in comparison to the 20-day moving average, which settled at $2.65. In addition, Erasca Inc saw 23.94% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ERAS starting from Erasca Foundation, who proposed sale 8,333 shares at the price of $2.68 back on Oct 15 ’24. After this action, Erasca Foundation now owns shares of Erasca Inc, valued at $22,306 using the latest closing price.
Erasca Foundation, the Affiliate of Erasca Inc, proposed sale 8,333 shares at $2.89 during a trade that took place back on Sep 16 ’24, which means that Erasca Foundation is holding shares at $24,090 based on the most recent closing price.
Stock Fundamentals for ERAS
Current profitability levels for the company are sitting at:
- -27.36 for the present operating margin
- 0.29 for the gross margin
The net margin for Erasca Inc stands at -28.37. The total capital return value is set at -0.3. Equity return is now at value -38.90, with -32.76 for asset returns.
Based on Erasca Inc (ERAS), the company’s capital structure generated 0.11 points at debt to capital in total, while cash flow to debt ratio is standing at -2.06. The debt to equity ratio resting at 0.12. The interest coverage ratio of the stock is -39.9.
Currently, EBITDA for the company is -137.79 million with net debt to EBITDA at 0.79. When we switch over and look at the enterprise to sales, we see a ratio of 112.36. The receivables turnover for the company is 2.54for trailing twelve months and the total asset turnover is 0.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 16.79.
Conclusion
In summary, Erasca Inc (ERAS) has had a mixed performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
